Brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma who are Ineligible for autologous stem cell transplant: A Germany and United Kingdom retrospective study
Paul J. Bröckelmann; Erin A. Zagadailov; Shelby L. Corman; Viktor Chirikov; Courtney Johnson; Cynthia Macahilig; Brian Seal; Mehul R. Dalal; Tim Illidge
Author Information: Department I of Internal Medicine and German Hodgkin Study Group (GHSG)
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.